Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Looking for a Treatment for the Early Stage of Alzheimer’s Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin
Roberta Facchinetti, Marta Valenza, Maria Rosanna Bronzuoli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3802-3802
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation Strategies
Umair Shabbir, Muhammad Sajid Arshad, Aysha Sameen, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 690-690
Open Access | Times Cited: 139
Immunopharmacological Activities of Luteolin in Chronic Diseases
Lei Huang, Mi‐Yeon Kim, Jae Youl Cho
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2136-2136
Open Access | Times Cited: 53
Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti‐inflammatory activity, and the gut microbiota‐liver‐brain axis
James W. Daily, Suna Kang, Sunmin Park
BioFactors (2020) Vol. 47, Iss. 2, pp. 218-231
Closed Access | Times Cited: 110
Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study
Pietro De Luca, Angelo Camaioni, Pasquale Marra, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2552-2552
Open Access | Times Cited: 57
Luteolin for neurodegenerative diseases: a review
Dunuvilla Kavindi Jayawickreme, Cletus Ekwosi, Apurva Anand, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 644-664
Open Access | Times Cited: 14
Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease
Lorenza Guarnieri, Francesca Bosco, Antonio Leo, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102210-102210
Open Access | Times Cited: 12
Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
Rengasamy Balakrishnan, Khoshnur Jannat, Dong‐Kug Choi
Redox Biology (2024) Vol. 71, pp. 103105-103105
Open Access | Times Cited: 11
The Potential Role of Polyphenols in Oxidative Stress and Inflammation Induced by Gut Microbiota in Alzheimer’s Disease
Umair Shabbir, Akanksha Tyagi, Fazle Elahi, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1370-1370
Open Access | Times Cited: 46
Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease
Ahsas Goyal, Kunal Solanki, Aanchal Verma
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 18
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD
Marta Valenza, Roberta Facchinetti, Carola Torazza, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets
Alessio Filippo Peritore, Rosalba Siracusa, Rosalia Crupi, et al.
Nutrients (2019) Vol. 11, Iss. 9, pp. 2175-2175
Open Access | Times Cited: 44
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries—A Systematic Review
Stefania Petrosino, Aniello Schiano Moriello
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9526-9526
Open Access | Times Cited: 41
Luteolin and Exercise Combination Therapy Ameliorates Amyloid-β1-42 Oligomers-Induced Cognitive Impairment in AD Mice by Mediating Neuroinflammation and Autophagy
Tao Xue, Rong Zhang, Liguo Wang, et al.
Journal of Alzheimer s Disease (2023) Vol. 92, Iss. 1, pp. 195-208
Closed Access | Times Cited: 12
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress
Tiziana Bonifacino, Jessica Mingardi, Roberta Facchinetti, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease
Vanessa D’Antongiovanni, Carolina Pellegrini, Luca Antonioli, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 24
Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence
Marco Colizzi, Riccardo Bortoletto, Chiara Colli, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 18
Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders
Martina Assogna, Francesco Di Lorenzo, Alessandro Martorana, et al.
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1161-1161
Open Access | Times Cited: 17
Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer’s Disease
Roberta Facchinetti, Marta Valenza, Chiara Gomiero, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1236-1236
Open Access | Times Cited: 14
Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
Marta Valenza, Roberta Facchinetti, Giorgia Menegoni, et al.
Biomolecules (2021) Vol. 11, Iss. 4, pp. 600-600
Open Access | Times Cited: 19
Tackling persistent neurological symptoms in patients following acute COVID-19 infection: an update of the literature
Eder Cáceres, Afshin A. Divani, André Emilio Viñán Garcés, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-17
Open Access | Times Cited: 2
Sorafenib Chemosensitization by Caryophyllane Sesquiterpenes in Liver, Biliary, and Pancreatic Cancer Cells: The Role of STAT3/ABC Transporter Axis
Silvia Di Giacomo, Marco Gullì, Roberta Facchinetti, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1264-1264
Open Access | Times Cited: 10
Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications
Marta Valenza, Roberta Facchinetti, Luca Steardo, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1191-1191
Open Access | Times Cited: 7
Successful and Unsuccessful Brain Aging in Pets: Pathophysiological Mechanisms behind Clinical Signs and Potential Benefits from Palmitoylethanolamide Nutritional Intervention
Caterina Scuderi, Lorenzo Golini
Animals (2021) Vol. 11, Iss. 9, pp. 2584-2584
Open Access | Times Cited: 6
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD
Caterina Scuderi, Marta Valenza, Roberta Facchinetti, et al.
Research Square (Research Square) (2024)
Open Access
Long COVID-19 and the potential use of palmitoylethanolamide
Rocco Salvatore Calabrò, Loredana Raciti
Elsevier eBooks (2024), pp. 429-439
Closed Access
Page 1 - Next Page

Scroll to top